Heterodimerization of Type A and B Cholecystokinin Receptors Enhance Signaling and Promote Cell Growth

Zhi Jie Cheng, Kaleeckal G. Harikumar, Eileen L. Holicky, Laurence J Miller

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

Dimerization of several G protein-coupled receptors has recently been described, but little is known about its clinical and functional relevance. Cholecystokinin (CCK) and gastrin are structurally related gastrointestinal and neuronal peptides whose functions are mediated by two structurally related receptors in this superfamily, the type A and B CCK receptors. We previously demonstrated spontaneous homodimerization of type A CCK receptors and the dissociation of those complexes by agonist occupation (Cheng, Z. J., and Miller, L. J. (2001) J. Biol. Chem. 276, 48040-48047). Here, for the first time, we also demonstrate spontaneous homodimerization of type B CCK receptors, as well as heterodimerization of that receptor with the type A CCK receptor. Unlike type A CCK receptor dimers, the homodimerization of type B CCK receptors was not affected by ligand occupation. However, although heterodimers of type A and B CCK receptors bound natural agonists normally, they exhibited unusual functional and regulatory characteristics. Such complexes demonstrated enhanced agonist-stimulated cellular signaling and delayed agonist-induced receptor internalization. As a likely consequence, agonist-stimulated cell growth was markedly enhanced in cells simultaneously expressing both of these receptors. Our results provide the first evidence that heterodimerization of G protein-coupled receptors can form a more "powerful" signaling unit, which has potential clinical significance in promoting cell growth.

Original languageEnglish (US)
Pages (from-to)52972-52979
Number of pages8
JournalJournal of Biological Chemistry
Volume278
Issue number52
DOIs
StatePublished - Dec 26 2003

Fingerprint

Cholecystokinin A Receptor
Cholecystokinin B Receptor
Cell growth
Growth
G-Protein-Coupled Receptors
Occupations
Cell signaling
Dimerization
Cholecystokinin
Gastrins
Dimers
Ligands
Peptides

ASJC Scopus subject areas

  • Biochemistry

Cite this

Heterodimerization of Type A and B Cholecystokinin Receptors Enhance Signaling and Promote Cell Growth. / Cheng, Zhi Jie; Harikumar, Kaleeckal G.; Holicky, Eileen L.; Miller, Laurence J.

In: Journal of Biological Chemistry, Vol. 278, No. 52, 26.12.2003, p. 52972-52979.

Research output: Contribution to journalArticle

Cheng, Zhi Jie ; Harikumar, Kaleeckal G. ; Holicky, Eileen L. ; Miller, Laurence J. / Heterodimerization of Type A and B Cholecystokinin Receptors Enhance Signaling and Promote Cell Growth. In: Journal of Biological Chemistry. 2003 ; Vol. 278, No. 52. pp. 52972-52979.
@article{70fd6455061844d0a5da882a9b455ddc,
title = "Heterodimerization of Type A and B Cholecystokinin Receptors Enhance Signaling and Promote Cell Growth",
abstract = "Dimerization of several G protein-coupled receptors has recently been described, but little is known about its clinical and functional relevance. Cholecystokinin (CCK) and gastrin are structurally related gastrointestinal and neuronal peptides whose functions are mediated by two structurally related receptors in this superfamily, the type A and B CCK receptors. We previously demonstrated spontaneous homodimerization of type A CCK receptors and the dissociation of those complexes by agonist occupation (Cheng, Z. J., and Miller, L. J. (2001) J. Biol. Chem. 276, 48040-48047). Here, for the first time, we also demonstrate spontaneous homodimerization of type B CCK receptors, as well as heterodimerization of that receptor with the type A CCK receptor. Unlike type A CCK receptor dimers, the homodimerization of type B CCK receptors was not affected by ligand occupation. However, although heterodimers of type A and B CCK receptors bound natural agonists normally, they exhibited unusual functional and regulatory characteristics. Such complexes demonstrated enhanced agonist-stimulated cellular signaling and delayed agonist-induced receptor internalization. As a likely consequence, agonist-stimulated cell growth was markedly enhanced in cells simultaneously expressing both of these receptors. Our results provide the first evidence that heterodimerization of G protein-coupled receptors can form a more {"}powerful{"} signaling unit, which has potential clinical significance in promoting cell growth.",
author = "Cheng, {Zhi Jie} and Harikumar, {Kaleeckal G.} and Holicky, {Eileen L.} and Miller, {Laurence J}",
year = "2003",
month = "12",
day = "26",
doi = "10.1074/jbc.M310090200",
language = "English (US)",
volume = "278",
pages = "52972--52979",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "52",

}

TY - JOUR

T1 - Heterodimerization of Type A and B Cholecystokinin Receptors Enhance Signaling and Promote Cell Growth

AU - Cheng, Zhi Jie

AU - Harikumar, Kaleeckal G.

AU - Holicky, Eileen L.

AU - Miller, Laurence J

PY - 2003/12/26

Y1 - 2003/12/26

N2 - Dimerization of several G protein-coupled receptors has recently been described, but little is known about its clinical and functional relevance. Cholecystokinin (CCK) and gastrin are structurally related gastrointestinal and neuronal peptides whose functions are mediated by two structurally related receptors in this superfamily, the type A and B CCK receptors. We previously demonstrated spontaneous homodimerization of type A CCK receptors and the dissociation of those complexes by agonist occupation (Cheng, Z. J., and Miller, L. J. (2001) J. Biol. Chem. 276, 48040-48047). Here, for the first time, we also demonstrate spontaneous homodimerization of type B CCK receptors, as well as heterodimerization of that receptor with the type A CCK receptor. Unlike type A CCK receptor dimers, the homodimerization of type B CCK receptors was not affected by ligand occupation. However, although heterodimers of type A and B CCK receptors bound natural agonists normally, they exhibited unusual functional and regulatory characteristics. Such complexes demonstrated enhanced agonist-stimulated cellular signaling and delayed agonist-induced receptor internalization. As a likely consequence, agonist-stimulated cell growth was markedly enhanced in cells simultaneously expressing both of these receptors. Our results provide the first evidence that heterodimerization of G protein-coupled receptors can form a more "powerful" signaling unit, which has potential clinical significance in promoting cell growth.

AB - Dimerization of several G protein-coupled receptors has recently been described, but little is known about its clinical and functional relevance. Cholecystokinin (CCK) and gastrin are structurally related gastrointestinal and neuronal peptides whose functions are mediated by two structurally related receptors in this superfamily, the type A and B CCK receptors. We previously demonstrated spontaneous homodimerization of type A CCK receptors and the dissociation of those complexes by agonist occupation (Cheng, Z. J., and Miller, L. J. (2001) J. Biol. Chem. 276, 48040-48047). Here, for the first time, we also demonstrate spontaneous homodimerization of type B CCK receptors, as well as heterodimerization of that receptor with the type A CCK receptor. Unlike type A CCK receptor dimers, the homodimerization of type B CCK receptors was not affected by ligand occupation. However, although heterodimers of type A and B CCK receptors bound natural agonists normally, they exhibited unusual functional and regulatory characteristics. Such complexes demonstrated enhanced agonist-stimulated cellular signaling and delayed agonist-induced receptor internalization. As a likely consequence, agonist-stimulated cell growth was markedly enhanced in cells simultaneously expressing both of these receptors. Our results provide the first evidence that heterodimerization of G protein-coupled receptors can form a more "powerful" signaling unit, which has potential clinical significance in promoting cell growth.

UR - http://www.scopus.com/inward/record.url?scp=0347992917&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0347992917&partnerID=8YFLogxK

U2 - 10.1074/jbc.M310090200

DO - 10.1074/jbc.M310090200

M3 - Article

C2 - 14534299

AN - SCOPUS:0347992917

VL - 278

SP - 52972

EP - 52979

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 52

ER -